BCYC
Bicycle Therapeutics
BCYC • NASDAQ
Bicycle Therapeutics is a pharmaceutical preparations company trading on NASDAQ, led by CEO Kevin Lee.
CEOKevin Lee
Next Earnings
Upcoming earnings announcement for Bicycle Therapeutics
Date
Thursday, April 30, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.57
Revenue Estimate
$8.4M
Earnings History
Past 12 earnings reports for Bicycle Therapeutics
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 17, 2026 | Q4 2025 | -$0.29Est: -$0.97 | +70.1% | $48.0MEst: $8.3M | +478.2% |  10-K |
| Oct 30, 2025 | Q3 2025 | -$0.85Est: -$1.08 | +21.3% | $11.7MEst: $9.1M | +28.6% | 10-Q |
| Aug 8, 2025 | Q2 2025 | -$1.14Est: -$0.94 | -21.3% | $2.9MEst: $9.2M | -68.3% | 10-Q |
| May 1, 2025 | Q1 2025 | -$0.88Est: -$0.81 | -8.6% | $10.0MEst: $8.7M | +15.1% | 10-Q |
| Feb 25, 2025 | Q4 2024 | -$0.75Est: -$0.88 | +14.8% | $3.7MEst: $5.3M | -30.6% | 10-K |
| Oct 31, 2024 | Q3 2024 | -$0.74Est: -$0.78 | +5.1% | $2.7MEst: $6.8M | -60.9% | 10-Q |
| Aug 6, 2024 | Q2 2024 | -$0.77Est: -$1.14 | +32.5% | $9.4MEst: $6.2M | +51.7% | 10-Q |
| May 2, 2024 | Q1 2024 | -$0.62Est: -$1.24 | +50.0% | $19.5MEst: $6.0M | +223.9% | 10-Q |
| Feb 20, 2024 | Q4 2023 | -$1.16Est: -$1.23 | +5.7% | $5.3MEst: $7.1M | -25.3% | 10-K |
| Nov 2, 2023 | Q3 2023 | -$1.26Est: -$1.17 | -7.7% | $5.4MEst: $13.1M | -59.1% | — |
| Aug 3, 2023 | Q2 2023 | -$1.41Est: -$1.29 | -9.3% | $11.4MEst: $4.6M | +148.8% | 10-Q |
| May 4, 2023 | Q1 2023 | -$1.30Est: -$1.07 | -21.5% | $4.9MEst: $3.9M | +26.2% | — |